Ilicicolin A Exerts Antitumor Effect in Castration-Resistant Prostate Cancer Via Suppressing EZH2 Signaling Pathway

• 主要な著者: Lang Guo (著者), Xiaowei Luo (著者), Ping Yang (著者), Yanting Zhang (著者), Jialuo Huang (著者), Hong Wang (著者), Yinfeng Guo (著者), Weifeng Huang (著者), Zhiqiang Chen (著者), Shusheng Wang (著者), Junjian Wang (著者), Jinping Lei (著者), Songtao Xiang (著者), Yonghong Liu (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2021-10-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

The Polycomb protein enhancer of zeste homolog 2 (EZH2) has critical roles in prostate cancer (PCa) progression and drug-resistance, which remains an obstacle for PCa treatment. Enzalutamide (ENZ) is a second-generation androgen receptor antagonist employed for treatment of metastatic castration-res...